Navigation Links
Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com
Date:6/19/2013

London, UK (PRWEB) June 19, 2013

In 2011, the value of the Serbian pharmaceutical market climbed to around EUR 710 million. Generic drugs form the largest sector, accounting for nearly one third of the total market value. The pharmaceutical industry is a significant contributor to the local economy; it accounts for over 3.2% of the country’s GDP. Approximately 50% of the total domestic chemical industry output fall to the share of the pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key participants in the Serbian pharmaceuticals market.

The Serbian pharmaceutical industry is poised for 7% growth annually through 2014. The generic and OTC drugs segments are likely to witness the strongest growth in the upcoming years. The sales of oral hygiene products are also forecast to register robust growth in the offing.

In-demand research report “Pharmaceutical Market Analysis” worked out by CUBE Risk Management Solutions has been recently published by Market Publishers Ltd.

Report Details:

Title: Pharmaceutical Market Analysis
Published: May, 2013
Pages: 85
Price: US$ 2,500.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/pharmaceutical-market-analysis.html

The report provides an insightful overview of the Serbian pharmaceutical market. It offers an in-depth analysis of the industry financial performance; uncovers information on production of medicines and foreign trade; traces price fluctuations, and draws up an accurate picture of the current situation on the market. The study reviews major manufacturers and trading companies; evaluates the market environment and outlines possible market risks. The research report describes key development trends of the industry and identifies prosperous and non-promising market players.

Report Scope:

  •     In-depth analysis of the Serbian pharmaceutical market and data on the legal entities active in the market.
  •     Financial analysis and benchmarking.
  •     Review of the current industry performance.
  •     Overview and analysis of leading manufacturers.
  •     Information on currently available medicines.
  •     Foreign trade statistics.
  •     Discussion of the most important issues.
  •     Examination of the prevailing development trends and data on the promising sectors.

More market research studies by the publisher can be found at CUBE page.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10848963.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... For over twenty-four years, Doctors on Liens ... personal injury victims find high quality medical care. When the company started in 1997, ... Fast forward to present day and the now ten-page directory features a vast array of ...
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to host ... other developmental disabilities. The group, which is being launched with the help of Robbie ... share stories and advice, seek help, and continue their education on how to best ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), ... Specialties, Inc. ("PSI").  The combination of Texas ... -based PSI bring together both company,s clinical expertise and ... payers an industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... MARLBOROUGH, Mass. , Dec. 2, 2016 ... announced a definitive agreement to acquire certain manufacturing assets ... NVCN ) (TSX: NVC) advanced biological tissue business, as ... a total of $75 million in cash. The Neovasc ... heart valves, including the Boston Scientific Lotus™ Valve System. ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
Breaking Medicine Technology: